299 related articles for article (PubMed ID: 5051257)
41. A controlled study of neuroleptization with fluphenazine hydrochloride injections.
Escobar JI; Barron A; Kiriakos R
J Clin Psychopharmacol; 1983 Dec; 3(6):359-62. PubMed ID: 6139394
[No Abstract] [Full Text] [Related]
42. Fluphenazine enanthate given to inpatients and outpatients.
Lambert PA; Marcou G
Dis Nerv Syst; 1970 Sep; 31():Suppl:63-5. PubMed ID: 4990945
[No Abstract] [Full Text] [Related]
43. The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
Dencker SJ
J Clin Psychiatry; 1984 May; 45(5 Pt 2):22-7. PubMed ID: 6143744
[TBL] [Abstract][Full Text] [Related]
44. [Clinical and ambulatory experiences with fluphenazine decanoate lyogen depot in prolonged therapy of psychiatric disorders].
Moldenhauer B
Med Welt; 1970 Jun; 25():1150-4. PubMed ID: 5512636
[No Abstract] [Full Text] [Related]
45. Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses.
Salvesen C; Vaksdal K
Behav Neuropsychiatry; 1973 Oct-1974 Mar; 5(7-12):3-7. PubMed ID: 4154740
[No Abstract] [Full Text] [Related]
46. [Clinical experimentation with benperidol].
Barre R; Chabrand P
Encephale; 1968; 57(4):353-66. PubMed ID: 5715041
[No Abstract] [Full Text] [Related]
47. [Clinical therapeutic experiences with fluphenazine].
Pfeiffer WM
Arzneimittelforschung; 1967 Oct; 17(10):1327-9. PubMed ID: 5632888
[No Abstract] [Full Text] [Related]
48. [Treatment of therapeutically resistant paranoid schizophrenic patients with Moditen-depot combined with other psychotropic drugs and Leponex].
Gamburg AL; Aranovich AG; Kotel'kevich IuN; Omorokov BM; Rasniuk VA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(8):1211-6. PubMed ID: 6111169
[TBL] [Abstract][Full Text] [Related]
49. Fluphenazine enanthate: a report of a clinical trial in psychotic patients.
Karkalas Y
Curr Ther Res Clin Exp; 1968 Apr; 10(4):196-200. PubMed ID: 4967873
[No Abstract] [Full Text] [Related]
50. [Treatment of schizophrenic psychoses by sustained-action neuroleptics in psychiatric outpatients' treatment (author's transl)].
Polácek J
Cesk Psychiatr; 1982 Feb; 78(1):49-55. PubMed ID: 7060182
[No Abstract] [Full Text] [Related]
51. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
Mamo DC; Sweet RA; Chengappa KN; Reddy RR; Jeste DV
Int J Geriatr Psychiatry; 2002 Nov; 17(11):1012-7. PubMed ID: 12404650
[TBL] [Abstract][Full Text] [Related]
52. [Comparative study of the action of fluphenazine oenanthate and decanoate in chronic psychoses (73 cases)].
Martin A; Masson JM; Quentin JC; Verrier JP; Jusseaume P
Ann Med Psychol (Paris); 1972 Dec; 2(5):705-8. PubMed ID: 4576210
[No Abstract] [Full Text] [Related]
53. [Long-term treatment of schizophrenic psychoses using retard-neuroleptic preparations].
Andreas W
Med Welt; 1972 Apr; 23(15):566-7. PubMed ID: 4624926
[No Abstract] [Full Text] [Related]
54. Differential study of 2 long-acting neuroleptics, fluphenazine enanthate and pipothiazine undecylenate.
Gayral LF; Escande MM; Fournie HC; Huron RJ
Therapie; 1973; 28(3):611-25. PubMed ID: 4771904
[No Abstract] [Full Text] [Related]
55. [Clinical observation on the effect of domestic fluphenazine decanoate in the treatment of schizophrenia---report of 431 cases (author's transl)].
Zhang YF
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Aug; 14(3):182-5. PubMed ID: 7333179
[No Abstract] [Full Text] [Related]
56. [Management of psychotic drive disorders].
Langner E
Wien Med Wochenschr; 1968 Sep; 118(36):700-2. PubMed ID: 5679053
[No Abstract] [Full Text] [Related]
57. Long-acting fluphenazine injections.
Drug Ther Bull; 1970 Aug; 8(18):69-71. PubMed ID: 5480246
[No Abstract] [Full Text] [Related]
58. [Remarks on the action of Moditen-retard and Modecate. Apropos of 65 cases].
Scherrer P; Quiniou-Vidalenc
Ann Med Psychol (Paris); 1976 Nov; 2(4):642-56. PubMed ID: 1020862
[No Abstract] [Full Text] [Related]
59. Plasma fluphenazine levels measured by high-performance liquid chromatography in patients treated with depot injections.
Jouen F; Verité P; André D; Colonna L; Boucly P
Arzneimittelforschung; 1993 May; 43(5):509-11. PubMed ID: 8328993
[TBL] [Abstract][Full Text] [Related]
60. [Prolonged action neuroleptics (review of the foreign literature)].
Obukhov GA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(2):285-95. PubMed ID: 235182
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
